Trump promis­es a safe, ef­fec­tive vac­cine for Covid-19 be­fore year’s end — 'or maybe even soon­er!' So where does that leave the FDA?

While FDA chief Stephen Hahn scram­bled to make the dif­fi­cult case that the FDA will stay on the straight and nar­row sci­en­tif­ic path in re­view­ing vac­cines for wide pub­lic use against the pan­dem­ic, Pres­i­dent Trump has laid down his own time­line and is­sued march­ing or­ders the agency will be hard pressed to ig­nore.

And he’s clear­ly leav­ing the door open to a snap OK ahead of the elec­tion.

On Thurs­day night, Trump used his na­tion­al speech ac­cept­ing the Re­pub­li­can nom­i­na­tion for a sec­ond term to promise the Amer­i­can peo­ple a “safe and ef­fec­tive” vac­cine with­in 4 months.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE